Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients

Inclusion Criteria: * PART I: Subjects must be adults with age \>= 18 years at the time of study entry * PART I: Subjects with any cancer diagnosis may be included * PART I: Subjects must be identified as new patients to hematology oncology at the treating site * PART I: Subjects must be willing to provide informed consent for the study * PART II: Subjects must be adults with age \>= 18 years at the time of study entry * PART II: Subjects with any cancer diagnosis may be included * PART II: Subjects must be identified as new patients to hematology oncology at the treating site * PART II: Subjects must be willing to provide informed consent for the study Exclusion Criteria: * PART I: Patients reported to have an estimated life-expectancy of \< 6 months, as assessed by their clinician * PART I: Patients not willing to complete the Clinical Trials Study survey * PART II: Patients reported to have an estimated life-expectancy of \< 6 months, as assessed by their clinician * PART II: Patients not willing to complete the education intervention or continued follow up for at least 2 years